Search hospitals > Ohio > Columbus
Riverside Methodist Hospital
Claim this profileColumbus, Ohio 43214
Global Leader in Skin Cancer
Global Leader in Relapse
Conducts research for Stomach Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast Cancer
389 reported clinical trials
30 medical researchers
Summary
Riverside Methodist Hospital is a medical facility located in Columbus, Ohio. This center is recognized for care of Skin Cancer, Relapse, Stomach Cancer, Ovarian Cancer, Breast Cancer and other specialties. Riverside Methodist Hospital is involved with conducting 389 clinical trials across 701 conditions. There are 30 research doctors associated with this hospital, such as Timothy D. Moore, Steven Yakubov, MD, Aine E. Clements, and Carlos Sanchez, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Relapse
Global LeaderStage IV
Stage III
Stage I
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center6 years of reported clinical research
Expert in Skin Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
Steven Yakubov, MDOhio Health Research Institute6 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Mitral Regurgitation
8 reported clinical trials
14 drugs studied
Aine E. ClementsOhioHealth Mansfield Hospital2 years of reported clinical research
Studies Ovarian Cancer
Studies Endometrial Cancer
7 reported clinical trials
32 drugs studied
Carlos Sanchez, MDOhioHealth Research Institute6 years of reported clinical research
Studies Mitral Regurgitation
Studies Stroke
6 reported clinical trials
10 drugs studied
Clinical Trials running at Riverside Methodist Hospital
Breast Cancer
Lung Cancer
Ovarian Cancer
Skin Cancer
Multiple Myeloma
Breast cancer
Cancer
Bladder Carcinoma
Bladder Cancer
Uterine Tumors
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Riverside Methodist Hospital?
Riverside Methodist Hospital is a medical facility located in Columbus, Ohio. This center is recognized for care of Skin Cancer, Relapse, Stomach Cancer, Ovarian Cancer, Breast Cancer and other specialties. Riverside Methodist Hospital is involved with conducting 389 clinical trials across 701 conditions. There are 30 research doctors associated with this hospital, such as Timothy D. Moore, Steven Yakubov, MD, Aine E. Clements, and Carlos Sanchez, MD.
Where is Riverside Methodist Hospital located?
OhioHealth Riverside Methodist Hospital is located at 3535 Olentangy River Road, Columbus, OH. For access from the North, use I-71 and follow the hospital signs.
Who should I call to ask about financial aid or insurance network?
**Riverside Methodist Hospital Financial Assistance:**
- For financial assistance, contact the Patient Financial Services department at (614) 566-5059. Assistance is available for patients with limited resources and inadequate medical insurance, based on family income and assets.
- For additional information, reach out to customer service at 800-837-2455.
**Insurance Inquiries:**
- Visit the Riverside Methodist Hospital website for details on accepted insurance plans and billing policies.
- For questions about charges, contact the OhioHealth Customer Call Center at (614) 566-1505 or toll-free at (844) 379-4962.
What insurance does Riverside Methodist Hospital accept?
Riverside Methodist Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Anthem, Buckeye Community Health Plan, Cigna, Devoted Health, Humana, Medical Mutual of Ohio, Molina, Ohio Health Choice, OhioHealthy Network, OhioHealthy Associate Health Plan, Prime Time Medicare PPO, Techniplas: Partners Direct Health, Tricare, and United Healthcare. Coverage spans commercial, Medicare, Medicaid, and military programs. It's crucial to verify your physician's acceptance of your insurance and confirm your benefits and coverage before your visit.
What awards or recognition has Riverside Methodist Hospital received?
Riverside Methodist Hospital, located in Columbus, Ohio, is renowned for its extensive maternity program, recognized as a Level III Maternity Center by the Ohio Department of Health. It is a key part of OhioHealth, a non-profit healthcare system that encompasses the OhioHealth Research Institute, promoting research and innovation across multiple medical disciplines.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.